LEHVOSS Nutrition offer Bacognize® which is a clean-label, natural standardized extract derived from Bacopa monnieri, clinically proven to support memory, mood, attention, focus, emotional balance and sleep, which offers complete nootropic support without stimulating side effects.
Research suggests that Bacognize® may help improve quality of sleep and support the regulation of sleep cycles. The latest published study on Bacognize® shows positive improvements in salivary biomarkers measures when compared to placebo, in all quality of life markers - 18% increase in alertness upon waking, 14% improvement in emotional wellbeing, 12% improvement in general health and 13% increase in salivary morning cortisol among other results. There were also positive changes in Post-Meridiem-Melatonin and decreases in CRP.1 The ability to improve grogginess was significant with no adverse effects observed in the Bacognize group attributed to supplementation.
Previous studies also looked at the mechanistic abilities of Bacognize® to interact on HT1a receptors associated with serotonin uptake. With this knowledge, researchers examined the ability of Bacognize® to act as an adaptogen, modulating the serotonin / melatonin pathways associated with alertness, focus, and a healthy circadian rhythm.2
Based on the benefits highlighted by the clinical research on Bacognize®, we suggest this ingredient may be a great addition to other traditional sleep aid food supplements such as melatonin, chamomile, valerian or lavender. These natural sleep aids are well known for encouraging relaxation, easing anxiety, and promoting sleep. So why not boost your existing formulation with an innovative ingredient to support alertness upon waking up?
- Lopresti A et al. Effects of a Bacopa monnieri extract (Bacognize®) on stress, fatigue, quality of life and sleep in adults with self-reported poor sleep: A randomised, double-blind, placebo-controlled study. Journal of Functional Foods, Volume 85, October 2021, 104671.
- Hall et al. Pharmacology of Bacopa monnieri (Bacognize®) at 5HT1a and 5HT2a receptors. Am Soc Pharmacog Absts. 2005. 83-85. Poster presentation in 46th Am Soc Pharmacog (ASP) Annual Meeting, Corvallis, OR.